Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol

References

• Jaffe E S, Harris N L, Stein H, Vardiman J W. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC), LyonFrance 2001
   Google Scholar
• Gasparini M, Lombardi F, Gianni M C, Lattuada A, Rilke F, Fossati-Bellani F. Childhood non-Hodgkin's lymphoma: prognostic relevance of clinical stage and histologic subgroups. Am J Pediatr Hematol Oncol 1983; 5: 161–171
   PubMedGoogle Scholar
• Anderson J, Jenkin R D, Wilson J F, Kjerdberg C R, Sposto R, Chilcote R R, et al. Long-term follow up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Children's Cancer Group. J Clin Oncol 1993; 11: 1024–1032
   PubMed Web of Science ®Google Scholar
• Bowman W P, Shuster J J, Cook B, Griffin T, Behm F, Pullen J, et al. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a Pediatric Oncology Group study. J Clin Oncol 1996; 14: 1252–1261
   PubMed Web of Science ®Google Scholar
• Brecher M L, Schwenn M R, Coppes M J, Bowmann W P, Link M P, Berard C W, et al. Fractionated cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group. Med Pediatr Oncol 1997; 29: 526–533
   PubMedGoogle Scholar
• Reiter A, Schrappe M, Tiemann M, Ludwig W D, Yakisan E, Zimmermann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of Berlin – Frankfurt – Munster Group Trial BFM 90. Blood 1999; 49: 3294–3306
   Google Scholar
• Atra A, Imeson J D, Hobson R, Gerrard M, Hann I M, Eden O B, et al. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) B9002 protocol. Br J Cancer 2000; 82: 1396–1402
   PubMed Web of Science ®Google Scholar
• Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Freppaz D, et al. The Societe Francasie d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001; 97: 3370–3379
   PubMed Web of Science ®Google Scholar
• Cairo M S, Krailo M D, Morse M, Hutchinson R J, Harris R E, Kjerdsberg C R, et al. Long-term follow-up of short intensive multiagent without high-dose methotrexate (‘Orange’) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a Children's Cancer Group report. Leukemia 2002; 16: 594–600
   PubMed Web of Science ®Google Scholar
• Spreafico F, Massimino M, Luksch R, Riccardi R, Tesoro-Tess J D, Gandola L, et al. Intensive very short chemotherapy for advanced Burkitt's lymphoma in children. J Clin Oncol 2002; 20: 2783–2788
   PubMed Web of Science ®Google Scholar
• Acquatella G, Insausti C L, Garcia R, Gomez R, Hernandez M, Carneiro M, et al. Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol. Pediatr Blood Cancer 2004; 43: 580–586
   PubMed Web of Science ®Google Scholar
• Murphy S B. Classification, staging and end results of treatment in childhood non-Hodgkin's lymphoma: dissimilarities from lymphomas in adults. Semin Oncol 1980; 7: 332–339
   PubMed Web of Science ®Google Scholar
• Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R, et al. Results of the randomized international trial of LMB-96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 2007; 109: 2773–2780
   PubMed Web of Science ®Google Scholar
• Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report from the BFM group study NHL-BFM95. Blood 2005; 105: 948–958
   PubMed Web of Science ®Google Scholar
• Cairo M S, Gerrard M, Sposto R, Auperin A, Pinkerton R, Michon J, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 2007; 109: 2736–2743
   PubMed Web of Science ®Google Scholar